Ensysce Biosciences, Inc. (LACQ) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1212057,
    "name": "Ensysce Biosciences, Inc.",
    "stock_name": "Ensysce Biosciences, Inc.",
    "full_name": "Ensysce Biosciences, Inc.",
    "name_url": "stocks-analysis/ensysce-biosciences-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "1.63",
    "chg": 0.06,
    "chgp": "3.82%",
    "dir": 1,
    "prev_price": "1.57",
    "mcapval": "6.23",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US2936024056",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "111.99 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ensysce-biosciences-inc-1212057-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Ensysce Biosciences, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-ensysce-biosciences-inc-technically-bullish-or-bearish-3548443",
        "imagepath": "",
        "date": "2025-09-20 20:17:43",
        "description": "As of 29 July 2025, the technical trend for Ensysce Biosciences, Inc. has changed from sideways to mildly bearish. The weekly MACD is mildly bullish, but the daily moving averages indicate a bearish stance. The Bollinger Bands are bearish on the weekly and mildly bearish on the monthly, while the KST shows a mildly bullish signal on both weekly and monthly time frames. The OBV is mildly bearish on the weekly, indicating some selling pressure. Overall, the mixed signals suggest a mildly bearish outlook with some strength in the longer-term indicators. There is no available return data for comparison with the S&P 500...."
      },
      {
        "title": "Is Ensysce Biosciences, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-ensysce-biosciences-inc-overvalued-or-undervalued-3544469",
        "imagepath": "",
        "date": "2025-09-20 18:47:11",
        "description": "As of 16 August 2021, the valuation grade for Ensysce Biosciences, Inc. moved from expensive to risky, indicating a shift in perception towards the company's financial health. The company appears to be overvalued given its current metrics, particularly with a Price to Book Value of 1.85 and negative ratios for EV to EBIT and EV to EBITDA at -0.41. Additionally, the Return on Capital Employed (ROCE) and Return on Equity (ROE) are significantly negative at -685.47% and -224.12%, respectively, which further underscores the company's challenges.\n\nIn comparison to its peer, ContraFect Corp., which has a positive EV to EBITDA of 0.1574, Ensysce's negative ratios highlight its underperformance in the industry. The overall valuation suggests that Ensysce is not only struggling financially but also lacks the metrics to justify its current price, reinforcing the notion that it is overvalued. While specific return dat..."
      }
    ],
    "total": 6,
    "sid": "1212057",
    "stock_news_url": "https://www.marketsmojo.com/news/ensysce-biosciences-inc-1212057"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Ensysce Biosciences, Inc. technically bullish or bearish?

2025-09-20 20:17:43

As of 29 July 2025, the technical trend for Ensysce Biosciences, Inc. has changed from sideways to mildly bearish. The weekly MACD is mildly bullish, but the daily moving averages indicate a bearish stance. The Bollinger Bands are bearish on the weekly and mildly bearish on the monthly, while the KST shows a mildly bullish signal on both weekly and monthly time frames. The OBV is mildly bearish on the weekly, indicating some selling pressure. Overall, the mixed signals suggest a mildly bearish outlook with some strength in the longer-term indicators. There is no available return data for comparison with the S&P 500....

Is Ensysce Biosciences, Inc. overvalued or undervalued?

2025-09-20 18:47:11

As of 16 August 2021, the valuation grade for Ensysce Biosciences, Inc. moved from expensive to risky, indicating a shift in perception towards the company's financial health. The company appears to be overvalued given its current metrics, particularly with a Price to Book Value of 1.85 and negative ratios for EV to EBIT and EV to EBITDA at -0.41. Additionally, the Return on Capital Employed (ROCE) and Return on Equity (ROE) are significantly negative at -685.47% and -224.12%, respectively, which further underscores the company's challenges. In comparison to its peer, ContraFect Corp., which has a positive EV to EBITDA of 0.1574, Ensysce's negative ratios highlight its underperformance in the industry. The overall valuation suggests that Ensysce is not only struggling financially but also lacks the metrics to justify its current price, reinforcing the notion that it is overvalued. While specific return dat...

View All News